Clinical phenotypes among patients with normal cardiac perfusion using unsupervised learning: a retrospective observational study
- PMID: 38168587
- PMCID: PMC10794922
- DOI: 10.1016/j.ebiom.2023.104930
Clinical phenotypes among patients with normal cardiac perfusion using unsupervised learning: a retrospective observational study
Abstract
Background: Myocardial perfusion imaging (MPI) is one of the most common cardiac scans and is used for diagnosis of coronary artery disease and assessment of cardiovascular risk. However, the large majority of MPI patients have normal results. We evaluated whether unsupervised machine learning could identify unique phenotypes among patients with normal scans and whether those phenotypes were associated with risk of death or myocardial infarction.
Methods: Patients from a large international multicenter MPI registry (10 sites) with normal perfusion by expert visual interpretation were included in this cohort analysis. The training population included 9849 patients, and external testing population 12,528 patients. Unsupervised cluster analysis was performed, with separate training and external testing cohorts, to identify clusters, with four distinct phenotypes. We evaluated the clinical and imaging features of clusters and their associations with death or myocardial infarction.
Findings: Patients in Clusters 1 and 2 almost exclusively underwent exercise stress, while patients in Clusters 3 and 4 mostly required pharmacologic stress. In external testing, the risk for Cluster 4 patients (20.2% of population, unadjusted hazard ratio [HR] 6.17, 95% confidence interval [CI] 4.64-8.20) was higher than the risk associated with pharmacologic stress (HR 3.03, 95% CI 2.53-3.63), or previous myocardial infarction (HR 1.82, 95% CI 1.40-2.36).
Interpretation: Unsupervised learning identified four distinct phenotypes of patients with normal perfusion scans, with a significant proportion of patients at very high risk of myocardial infarction or death. Our results suggest a potential role for patient phenotyping to improve risk stratification of patients with normal imaging results.
Funding: This work was supported by the National Heart, Lung, and Blood Institute at the National Institutes of Health [R35HL161195 to PS]. The REFINE SPECT database was supported by the National Heart, Lung, and Blood Institute at the National Institutes of Health [R01HL089765 to PS]. MCW was supported by the British Heart Foundation [FS/ICRF/20/26002].
Keywords: Cluster analysis; Coronary artery disease; Machine learning; Myocardial perfusion.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of interests Dr. Robert Miller has received consulting and research support from Pfizer. Drs Berman and Slomka participate in software royalties for QPS software at Cedars-Sinai Medical Center. Dr Williams serves as the President-Elect of the British Society of Cardiovascular Imaging and is on the Board of Directors for the Society of Cardiovascular Computed Tomography; she has received consulting support from FEOPS and has given lectures for Canon Medical Systems, Siemens Healthineers and Novartis. Dr. Pieszko has served as a consultant for Medicalgorithmics S.A. Dr. Slomka has received consulting fees from Synektik. Drs. Berman, Sharir, Kaufmann, and Edward Miller have served as consultants for GE Healthcare. Dr. Dorbala has received honoraria from Novo Nordisk and Pfizer; her institution has received grant support from Attralus, Pfizer, GE Healthcare, Siemans, and Phillips. Dr. DiCarli has received institutional research grant support from Gilead Sciences and Amgen and consulting honoraria from Sanofi, Valo Health and MedTrace. Dr. Ruddy has received research grant support from GE Healthcare and Pfizer. Dr. Edward Miller has served as a consultant for ROIVANT; has received grant support from Anylam, Pfizer and Siemens, and has participated on the study advisory board of BioBridge. Dr. Sinusas serves a leadership role on the Society of Nuclear Medicine and Molecular Imaging Cardiovascular Council. Dr. Einstein receives royalties from Wolters Kluwer UpToDate and the American Society of Nuclear Cardiology/Society of Nuclear Medicine and Molecular Imaging, consulting fees from W.L Gore & Associates, support through patents with Columbia Technology Ventures, and has given lectures for Ionetix. Dr. Einstein's institution has received research support from GE Healthcare, Roche Medical Systems, W. L. Gore & Associates, Eidos Therapeutics, Attralus, Pfizer, Neovasc, Intellia Therapeutics, Ionis Pharmaceuticals, Canon Medical Systems, the International Atomic Energy Agency, National Council on Radiation Protection and Measurements, and the United States Regulatory Commission. The remaining authors have nothing to disclose.
Figures






Similar articles
-
Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging.Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2656-2668. doi: 10.1007/s00259-023-06218-z. Epub 2023 Apr 17. Eur J Nucl Med Mol Imaging. 2023. PMID: 37067586 Free PMC article.
-
Risk stratification among diabetic patients undergoing stress myocardial perfusion imaging.J Nucl Cardiol. 2013 Aug;20(4):529-38. doi: 10.1007/s12350-013-9731-1. Epub 2013 May 24. J Nucl Cardiol. 2013. PMID: 23703380
-
The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging.J Nucl Cardiol. 2022 Apr;29(2):826-835. doi: 10.1007/s12350-020-02375-y. Epub 2020 Oct 9. J Nucl Cardiol. 2022. PMID: 33034835
-
Prognostic Value of Myocardial Perfusion Analysis in Patients with Coronary Artery Disease: A Meta-Analysis.J Am Soc Echocardiogr. 2017 Mar;30(3):270-281. doi: 10.1016/j.echo.2016.11.015. Epub 2016 Dec 31. J Am Soc Echocardiogr. 2017. PMID: 28049598 Review.
-
Reversible myocardial perfusion defects in patients not suffering from obstructive epicardial coronary artery disease as assessed by coronary angiography.Q J Nucl Med Mol Imaging. 2018 Sep;62(3):325-335. doi: 10.23736/S1824-4785.16.02875-2. Epub 2016 Mar 23. Q J Nucl Med Mol Imaging. 2018. PMID: 27007665 Review.
Cited by
-
Kynurenic Acid Is a Predictive Prognostic Metabolic Marker in ST-Elevation Myocardial Infarction.Cardiovasc Ther. 2025 Jul 17;2025:9123654. doi: 10.1155/cdr/9123654. eCollection 2025. Cardiovasc Ther. 2025. PMID: 40709077 Free PMC article.
-
Identifying at-risk patients for congenital heart disease using integrated predictive models and fuzzy clustering analysis: A cross-sectional study.Heliyon. 2024 Oct 18;10(20):e39609. doi: 10.1016/j.heliyon.2024.e39609. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39498045 Free PMC article.
-
Predicting major cardiac and cerebrovascular events in acute coronary syndrome patients using the thyroid hormone sensitivity index.Front Endocrinol (Lausanne). 2025 Jul 2;16:1543378. doi: 10.3389/fendo.2025.1543378. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40671909 Free PMC article.
-
Unsupervised Machine Learning in Identification of Septic Shock Phenotypes and Their In-Hospital Outcomes: A Multicenter Cohort Study.J Clin Med. 2025 Jun 23;14(13):4450. doi: 10.3390/jcm14134450. J Clin Med. 2025. PMID: 40648824 Free PMC article.
-
MedAlmighty: enhancing disease diagnosis with large vision model distillation.Front Artif Intell. 2025 Aug 12;8:1527980. doi: 10.3389/frai.2025.1527980. eCollection 2025. Front Artif Intell. 2025. PMID: 40873493 Free PMC article.
References
-
- Gulati M., Levy P.D., Mukherjee D., et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain. Circulation. 2021;144(22):e368–e454. - PubMed
-
- Berman D.S., Abidov A., Kang X., et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol. 2004;11(4):414–423. - PubMed
-
- Rozanski A., Gransar H., Hayes S.W., et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol. 2013;61(10):1054–1065. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical